HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
195546.0,217626,2192-01-12 05:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint:  SOB
   24 Hour Events:
   - briefly on BIPAP for approximately 1 hour, then weaned down to
   ventimask at 30%
   - blood gases show improvement of pH and PCO2
   - given ceftaz/levaquin
   - diuresed 1L with 20 of lasix IV
   - given solumedrol and nebs
   - respiratory status overall significantly improved
   Allergies:
   [**Last Name (un) 4586**] Dayquil Cough (Oral) (Dextromethorphan Hbr)
   pt. is allergic
   Last dose of Antibiotics:
   Levofloxacin - [**2192-1-11**] 04:30 PM
   Ceftazidime - [**2192-1-11**] 10:10 PM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2192-1-12**] 12:10 AM
   Metoprolol - [**2192-1-12**] 04:13 AM
   Other medications:
   Metoprolol 12.5 [**Hospital1 7**]
   Levaquin 750 daily
   Aspirin 325 daily
   Flomax 0.4 hs
   Atrovent nebs
   Albuterol nebs
   Methylpred 125 IV q 8 hours
   HSQ
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2192-1-12**] 05:50 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 95 (82 - 114) bpm
   BP: 152/69(99) {108/50(73) - 160/89(117)} mmHg
   RR: 18 (10 - 22) insp/min
   SpO2: 90%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                    238 mL
                                                                     29 mL
   PO:
             TF:
   IVF:
                                                                    238 mL
                                                                     29 mL
   Blood products:
   Total out:
                                                                  1,270 mL
                                                                    160 mL
   Urine:
                                                                  1,270 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,033 mL
                                                                   -131 mL
   Respiratory support
   O2 Delivery Device: Venti mask
   Ventilator mode: Standby
   Vt (Spontaneous): 618 (618 - 848) mL
   PS : 12 cmH2O
   RR (Spontaneous): 0
   PEEP: 6 cmH2O
   FiO2: 40%
   PIP: 0 cmH2O
   SpO2: 90%
   ABG: 7.31/74/67/37/6
   Ve: 2.8 L/min
   PaO2 / FiO2: 168
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, anicteric sclear
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Wheezes : diffuse wheezes,
   Diminished: b/l), poor air entry
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Follows simple commands, Responds to: Not assessed,
   Oriented (to): x3, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   223 K/uL
   15.1 g/dL
   147 mg/dL
   0.8 mg/dL
   37 mEq/L
   4.4 mEq/L
   29 mg/dL
   99 mEq/L
   141 mEq/L
   45.0 %
   3.4 K/uL
        [image002.jpg]
                            [**2192-1-11**]  01:39 PM
                            [**2192-1-11**]  01:45 PM
                            [**2192-1-11**]  04:52 PM
                            [**2192-1-11**]  08:44 PM
                            [**2192-1-11**]  08:54 PM
                            [**2192-1-12**]  01:57 AM
                            [**2192-1-12**]  02:35 AM
   WBC
   3.4
   Hct
   45.0
   Plt
   223
   Cr
   0.8
   TropT
   0.02
   <0.01
   TCO2
   36
   36
   39
   39
   39
   Glucose
   147
   Other labs: PT / PTT / INR:14.8/34.6/1.3, CK / CKMB /
   Troponin-T:91//<0.01, ALT / AST:20/19, Alk Phos / T Bili:78/0.4,
   Differential-Neuts:88.5 %, Lymph:8.2 %, Mono:2.8 %, Eos:0.2 %, Lactic
   Acid:1.4 mmol/L, Albumin:3.5 g/dL, LDH:190 IU/L, Ca++:8.4 mg/dL,
   Mg++:1.9 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   Assessment and Plan
   Mr.  [**Known lastname 4584**] is a 75 year old male with severe COPD, prostate ca s/p
   lupron and brachytherapy, PAF, urinary retention who presents with
   respiratory distress, likely secondary to COPD exacerbation..
   .
   1.  Respiratory failure.  Patient is known to have COPD.  His blood
   gasses show significant hypercarbia and there is wheezing on exam,
   making COPD exacerbation the most likely diagnosis.  Patient had
   significant improvement with nebs, steroids, antibiotics, lasix.  Got
   ceftaz/levaquin to cover severe CAP, however [**First Name8 (NamePattern2) **] [**Last Name (un) 4605**] ceftaz given
   lack of cough, fever, wbc or clinical suggestion of pneumonia.   He
   diuresed 1L with lasix, but appears euvolemic so will hold off on
   further diuresis.
   - albuterol, atrovent nebs
   - solumedrol 125 IV q 8 hours
 transition to prednisone tomorrow
   - levaquin, d/c ceftaz
   - BIPAP as needed for pH < 7.20 or pCO2> 90 or respiratory distress
   - titrate supplemental oxygen to keep sats 88-92%
   - f/u blood and sputum cultures
   - follow fever curve and WBC
   .
   2.  HTN.  Patient has HTN.  Was previously on metoprolol and diltiazem
   at unclear doses.  However, patient unclear as to what medications he
   currently takes and his pharmacy (CVS in [**Location (un) 1714**] (zip code [**Numeric Identifier 4587**]) is
   currently closed.
   - transition from iv lopressor to PO lopressor
   - follow BP, HR
   .
   3.  PAF.  Patient has a history of PAF.  Currently in NSR.  Not
   currently antocoagulated.
   - continue BB
   - continue monitor on tele
   - aspirin
   .
   4. Urinary retention.  Has history of prostate cancer s/p brachytherapy
   with history of subsequent urinary retention.
   - continue flomax
   ICU Care
   Nutrition: advance diet to regular diet
   Glycemic Control:
   Lines:
   18 Gauge - [**2192-1-11**] 02:16 PM
   20 Gauge - [**2192-1-11**] 02:20 PM
   Arterial Line - [**2192-1-11**] 04:30 PM
   Prophylaxis:
   DVT: HSQ
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments: wife (understands some english) and daughter
   (english speaking)
   Code status: wife
   Disposition: consider callout in afternoon if stable
","Summary of Progress Note:
The patient is a 75-year-old male with severe COPD, prostate cancer, PAF, and urinary retention. He presented with respiratory distress, likely secondary to a COPD exacerbation. The patient's blood gases show significant hypercarbia and there is wheezing on exam. There was significant improvement with nebs, steroids, antibiotics, and lasix. 

Potential Medical Complications:
1. Respiratory failure: The patient's severe COPD puts him at risk for respiratory failure. The improvement with nebs, steroids, antibiotics, and lasix suggests a COPD exacerbation as the most likely diagnosis. 
2. Hypertension (HTN): The patient has a history of HTN. His current blood pressure is 152/69 mmHg. It is important to monitor and manage his blood pressure in the ICU.
3. Pulmonary embolism and deep vein thrombosis (PAF and DVT): The patient has a history of PAF and should be monitored for any signs of pulmonary embolism. Additionally, the use of HSQ for DVT prophylaxis is noted.
4. Urinary retention: The patient has a history of prostate cancer and subsequent urinary retention. It is important to continue monitoring his urinary function and continue with flomax.
5. Infection: Although not explicitly mentioned in the assessment, the patient received antibiotics, suggesting a concern for infection. Monitoring for signs of infection and adjusting antibiotic"
195546.0,217626,2192-01-12 05:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 NON-INVASIVE VENTILATION - START [**2192-1-11**] 02:51 PM
   1451 NIV initiated CPAP + PS  6PEEP 12 PS 40%.
 NON-INVASIVE VENTILATION - START [**2192-1-11**] 03:35 PM
 NON-INVASIVE VENTILATION - STOP [**2192-1-11**] 04:08 PM
 ARTERIAL LINE - START [**2192-1-11**] 04:30 PM
   Allergies:
   [**Last Name (un) 4586**] Dayquil Cough (Oral) (Dextromethorphan Hbr)
   pt. is allergic
   Last dose of Antibiotics:
   Levofloxacin - [**2192-1-11**] 04:30 PM
   Ceftazidime - [**2192-1-11**] 10:10 PM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2192-1-12**] 12:10 AM
   Metoprolol - [**2192-1-12**] 04:13 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2192-1-12**] 05:50 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 95 (82 - 114) bpm
   BP: 152/69(99) {108/50(73) - 160/89(117)} mmHg
   RR: 18 (10 - 22) insp/min
   SpO2: 90%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                    238 mL
                                                                     29 mL
   PO:
             TF:
   IVF:
                                                                    238 mL
                                                                     29 mL
   Blood products:
   Total out:
                                                                  1,270 mL
                                                                    160 mL
   Urine:
                                                                  1,270 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,033 mL
                                                                   -131 mL
   Respiratory support
   O2 Delivery Device: Venti mask
   Ventilator mode: Standby
   Vt (Spontaneous): 618 (618 - 848) mL
   PS : 12 cmH2O
   RR (Spontaneous): 0
   PEEP: 6 cmH2O
   FiO2: 40%
   PIP: 0 cmH2O
   SpO2: 90%
   ABG: 7.31/74/67/37/6
   Ve: 2.8 L/min
   PaO2 / FiO2: 168
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   223 K/uL
   15.1 g/dL
   147 mg/dL
   0.8 mg/dL
   37 mEq/L
   4.4 mEq/L
   29 mg/dL
   99 mEq/L
   141 mEq/L
   45.0 %
   3.4 K/uL
        [image002.jpg]
                            [**2192-1-11**]  01:39 PM
                            [**2192-1-11**]  01:45 PM
                            [**2192-1-11**]  04:52 PM
                            [**2192-1-11**]  08:44 PM
                            [**2192-1-11**]  08:54 PM
                            [**2192-1-12**]  01:57 AM
                            [**2192-1-12**]  02:35 AM
   WBC
   3.4
   Hct
   45.0
   Plt
   223
   Cr
   0.8
   TropT
   0.02
   <0.01
   TCO2
   36
   36
   39
   39
   39
   Glucose
   147
   Other labs: PT / PTT / INR:14.8/34.6/1.3, CK / CKMB /
   Troponin-T:91//<0.01, ALT / AST:20/19, Alk Phos / T Bili:78/0.4,
   Differential-Neuts:88.5 %, Lymph:8.2 %, Mono:2.8 %, Eos:0.2 %, Lactic
   Acid:1.4 mmol/L, Albumin:3.5 g/dL, LDH:190 IU/L, Ca++:8.4 mg/dL,
   Mg++:1.9 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
 RESPIRATORY FAILURE, CHRONIC
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2192-1-11**] 02:16 PM
   20 Gauge - [**2192-1-11**] 02:20 PM
   Arterial Line - [**2192-1-11**] 04:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","Summary:
The patient is a 45-year-old male admitted to the ICU with chronic respiratory failure. He has been on non-invasive ventilation, including CPAP and PS, due to his condition. The patient's allergies include a reaction to Dayquil cough syrup containing dextromethorphan Hbr. He received antibiotics, specifically levofloxacin and ceftazidime, on 1/11/2192 at 4:30 PM and 10:10 PM respectively. Heparin sodium was initiated for prophylaxis on 1/12/2192 at 12:10 AM, followed by metoprolol at 4:13 AM. The patient's vital signs show a temperature of 36.8 C (98.2 F), heart rate of 95 bpm, blood pressure ranging from 152/69 to 160/89 mmHg, respiratory rate of 18 inspiratory minutes, and oxygen saturation of 90%. His heart rhythm is sinus tachycardia. Fluid balance shows an input of 238 mL and output of 1,270 mL, with a negative balance of -1,033 mL. The patient is receiving respiratory support through a Venti mask with standby ventilation mode, with a tidal volume of 618 mL, peak inspiratory pressure of 12 cmH2O, respiratory rate of 0, fractional inspiratory time of 40%, positive end-expiratory pressure of 6 cmH"
195546.0,217626,2192-01-12 05:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 NON-INVASIVE VENTILATION - START [**2192-1-11**] 02:51 PM
   1451 NIV initiated CPAP + PS  6PEEP 12 PS 40%.
 NON-INVASIVE VENTILATION - START [**2192-1-11**] 03:35 PM
 NON-INVASIVE VENTILATION - STOP [**2192-1-11**] 04:08 PM
 ARTERIAL LINE - START [**2192-1-11**] 04:30 PM
   Allergies:
   [**Last Name (un) 4586**] Dayquil Cough (Oral) (Dextromethorphan Hbr)
   pt. is allergic
   Last dose of Antibiotics:
   Levofloxacin - [**2192-1-11**] 04:30 PM
   Ceftazidime - [**2192-1-11**] 10:10 PM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2192-1-12**] 12:10 AM
   Metoprolol - [**2192-1-12**] 04:13 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2192-1-12**] 05:50 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.8
   HR: 95 (82 - 114) bpm
   BP: 152/69(99) {108/50(73) - 160/89(117)} mmHg
   RR: 18 (10 - 22) insp/min
   SpO2: 90%
   Heart rhythm: ST (Sinus Tachycardia)
             Total In:
                                                                    238 mL
                                                                     29 mL
   PO:
             TF:
   IVF:
                                                                    238 mL
                                                                     29 mL
   Blood products:
   Total out:
                                                                  1,270 mL
                                                                    160 mL
   Urine:
                                                                  1,270 mL
                                                                    160 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,033 mL
                                                                   -131 mL
   Respiratory support
   O2 Delivery Device: Venti mask
   Ventilator mode: Standby
   Vt (Spontaneous): 618 (618 - 848) mL
   PS : 12 cmH2O
   RR (Spontaneous): 0
   PEEP: 6 cmH2O
   FiO2: 40%
   PIP: 0 cmH2O
   SpO2: 90%
   ABG: 7.31/74/67/37/6
   Ve: 2.8 L/min
   PaO2 / FiO2: 168
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, anicteric sclear
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Wheezes : diffuse wheezes,
   Diminished: b/l), poor air entry
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Follows simple commands, Responds to: Not assessed,
   Oriented (to): x3, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   223 K/uL
   15.1 g/dL
   147 mg/dL
   0.8 mg/dL
   37 mEq/L
   4.4 mEq/L
   29 mg/dL
   99 mEq/L
   141 mEq/L
   45.0 %
   3.4 K/uL
        [image002.jpg]
                            [**2192-1-11**]  01:39 PM
                            [**2192-1-11**]  01:45 PM
                            [**2192-1-11**]  04:52 PM
                            [**2192-1-11**]  08:44 PM
                            [**2192-1-11**]  08:54 PM
                            [**2192-1-12**]  01:57 AM
                            [**2192-1-12**]  02:35 AM
   WBC
   3.4
   Hct
   45.0
   Plt
   223
   Cr
   0.8
   TropT
   0.02
   <0.01
   TCO2
   36
   36
   39
   39
   39
   Glucose
   147
   Other labs: PT / PTT / INR:14.8/34.6/1.3, CK / CKMB /
   Troponin-T:91//<0.01, ALT / AST:20/19, Alk Phos / T Bili:78/0.4,
   Differential-Neuts:88.5 %, Lymph:8.2 %, Mono:2.8 %, Eos:0.2 %, Lactic
   Acid:1.4 mmol/L, Albumin:3.5 g/dL, LDH:190 IU/L, Ca++:8.4 mg/dL,
   Mg++:1.9 mg/dL, PO4:5.2 mg/dL
   Assessment and Plan
   Assessment and Plan
   Mr.  [**Known lastname 4584**] is a 75 year old male with severe COPD, prostate ca s/p
   lupron and brachytherapy, PAF, urinary retention who presents today
   with respiratory distress, likely secondary to COPD exacerbation +/-
   CHF and pneumonia.
   .
   1.  Respiratory failure.  Patient is known to have COPD, s/p
   pneumothorax x 2 treated with pleuradesis.  No prior PFTs in our
   records.  His blood gasses show significant hypercarbia and there is
   wheezing on exam, making COPD exacerbation the most likely diagnosis.
   However, will cover for pneumonia with ceftaz/levaquin given patients
   cough and CXR.  Will diurese gently in case there is an element of CHF
   though this seems less likely given normal BNP.  Prior echo shows
   pulmonary hypertension with RV hypertrophy and dilitation.
   - albuterol, atrovent nebs
   - solumedrol 125 IV q 8 hours
   - levaquin/ceftaz
   - BIPAP as needed for pH < 7.20 or pCO2> 90 or respiratory distress
   - titrate supplemental oxygen to keep sats 88-92%
   - lasix IV 20 x 1 with goal negative 500 - 1 L negative tonight
   - repeat CXR in AM post diuresis
   - ROMI
   - f/u blood and sputum cultures
   - follow fever curve and WBC
   .
   2.  HTN.  Patient has HTN.  Was previously on metoprolol and diltiazem
   at unclear doses.  However, patient unclear as to what medications he
   currently takes and his pharmacy (CVS in [**Location (un) 1714**] (zip code [**Numeric Identifier 4587**]) is
   currently closed.
   - metoprolol IV 5 q 4 hours and titrate as needed for HR and BP
   control; will transition to orals when diet is advanced
   .
   3.  PAF.  Patient has a history of PAF.  Currently in NSR.  Not
   currently antocoagulated.
   - continue BB
   - continue monitor on tele
   - aspirin
   .
   4. Urinary retention.  Has history of prostate cancer s/p brachytherapy
   with history of subsequent urinary retention.
   - continue flomax
   .
   Prophylaxis: HSQ
   FEN: NPO for now pending improvement of respiratory status
   CODE: Full code
   Communication: wife (understands some english) and daughter (english
   speaking)
 RESPIRATORY FAILURE, CHRONIC
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2192-1-11**] 02:16 PM
   20 Gauge - [**2192-1-11**] 02:20 PM
   Arterial Line - [**2192-1-11**] 04:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","Summary of Progress Note:
The patient is a 75-year-old male with severe COPD, prostate cancer (s/p lupron and brachytherapy), peripheral artery disease (PAF), urinary retention, who presents with respiratory distress. The likely diagnosis is a COPD exacerbation possibly secondary to pneumonia and congestive heart failure (CHF). The patient has a history of pneumothorax treated with pleuradesis. Initial treatment includes nebulized albuterol and atrovent, IV solumedrol, levofloxacin/ceftazidime, BIPAP as needed, supplemental oxygen, IV lasix for fluid management, and ROMI. Other medical issues include hypertension, for which the patient was previously on metoprolol and diltiazem, but current medication doses are unclear. The patient's pharmacy is closed, so IV metoprolol is being started for BP and HR control. The patient also has a history of PAF and is not currently anticoagulated. Urinary retention is also present due to a history of prostate cancer treatment. The patient is NPO pending improvement of respiratory status. Code status is full code. ICU care includes nutrition support, glycemic control, arterial line placement, and prophylaxis against DVT, stress ulcers, and ventilator-associated pneumonia (VAP)."
195546.0,217626,2192-01-13 06:28:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   Transitioned from facemask to nasal canula.
   Allergies:
   [**Last Name (un) 4586**] Dayquil Cough (Oral) (Dextromethorphan Hbr)
   pt. is allergic
   Last dose of Antibiotics:
   Levofloxacin - [**2192-1-11**] 04:30 PM
   Ceftazidime - [**2192-1-12**] 09:00 AM
   Infusions:
   Other ICU medications:
   Metoprolol - [**2192-1-12**] 08:18 AM
   Heparin Sodium (Prophylaxis) - [**2192-1-12**] 08:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2192-1-13**] 06:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 36.6
C (97.9
   HR: 93 (87 - 104) bpm
   BP: 134/58(90) {111/45(73) - 148/66(97)} mmHg
   RR: 14 (11 - 20) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    170 mL
                                                                     32 mL
   PO:
             TF:
   IVF:
                                                                    170 mL
                                                                     32 mL
   Blood products:
   Total out:
                                                                    990 mL
                                                                    290 mL
   Urine:
                                                                    990 mL
                                                                    290 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -820 mL
                                                                   -258 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.26/91.[**Numeric Identifier 143**]/137/39/10
   PaO2 / FiO2: 343
   Repeat ABG after O2 reduced to 2L and pt awake:
   ABG 7.33/66/56
   Physical Examination
   General Appearance: Thin, but not cichectic
   Eyes / Conjunctiva: PERRL, anicteric sclear
   Head, Ears, Nose, Throat: Normocephalic, op wnl, no JVD,
   Cardiovascular: RRR s1, s2 wnl, no m/r/g
   Respiratory / Chest: CTA bil, scattered bibasilar rales, poor air entry
   bilaterally.
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: DP 2+ bil.
   Skin:  Warm dry, normal
   Neurologic: CN II-XII grossly intact, strength 5/5 upper and lower.
   Labs / Radiology
   220 K/uL
   14.1 g/dL
   141 mg/dL
   0.8 mg/dL
   39 mEq/L
   5.1 mEq/L
   32 mg/dL
   100 mEq/L
   141 mEq/L
   42.1 %
   4.8 K/uL
        [image002.jpg]
   Hemolyzed sample
                            [**2192-1-11**]  04:52 PM
                            [**2192-1-11**]  08:44 PM
                            [**2192-1-11**]  08:54 PM
                            [**2192-1-12**]  01:57 AM
                            [**2192-1-12**]  02:35 AM
                            [**2192-1-12**]  08:17 AM
                            [**2192-1-12**]  12:35 PM
                            [**2192-1-12**]  06:07 PM
                            [**2192-1-13**]  02:24 AM
                            [**2192-1-13**]  02:57 AM
   WBC
   3.4
   4.8
   Hct
   45.0
   42.1
   Plt
   223
   220
   Cr
   0.8
   0.8
   TropT
   0.02
   <0.01
   TCO2
   39
   39
   39
   37
   37
   36
   43
   Glucose
   147
   141
   Other labs: PT / PTT / INR:14.8/34.6/1.3, CK / CKMB /
   Troponin-T:91//<0.01, ALT / AST:20/19, Alk Phos / T Bili:78/0.4,
   Differential-Neuts:88.5 %, Lymph:8.2 %, Mono:2.8 %, Eos:0.2 %, Lactic
   Acid:0.8 mmol/L, Albumin:3.5 g/dL, LDH:190 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.2 mg/dL, PO4:4.4 mg/dL
   MICRO: BCx pending, NGTD
   Assessment and Plan
   Mr.  [**Known lastname 4584**] is a 75 year old male with severe COPD, prostate ca s/p
   lupron and brachytherapy, PAF, urinary retention who presents with
   respiratory distress, likely secondary to COPD exacerbation..
   .
   1.  Respiratory failure.  Patient is known to have COPD.  His blood
   gasses showed significant hypercarbia and he was initially wheezing on
   exam, making COPD exacerbation the most likely diagnosis.  Patient had
   significant improvement with nebs, steroids, antibiotics, lasix.  Got
   ceftaz/levaquin to cover severe CAP, however ceftaz stopped given lack
   of cough, fever, wbc or clinical suggestion of pneumonia.   He
   initially diuresed 1L with lasix, but appeared euvolemic so did not
   have significant further lasix.
   - change albuterol, atrovent nebs to home meds of
   Spiriva/Combivent/Duoneb
   - change solumedrol 125 IV q 8 hours  to Prednisone 40mg PO daily with
   likely taper over 7 days when d/c
   - Continue Levofloxacin PO now day [**3-23**],
   - BIPAP as needed for pH < 7.20 or pCO2> 90 or respiratory distress
   - titrate supplemental oxygen to keep sats 88-92%
   - f/u blood and sputum cultures
   .
   2.  HTN.  Patient has HTN.  Home cardiac meds appear to be diltiazem
   240mg [**Hospital1 7**] and no BB as well as cozar.  Meds doses taken from PCP by
   phone (from memory) which agreed with paperwork from [**Hospital3 4627**].
   - change lopressor to Diltiazem 60mg QID (to reach
 home dose)
   - will hold off on Losartan until stable with Diltiazem (should be
   restarted on floor tomorrow)
   - follow BP, HR
   .
   3.  PAF.  Patient has a history of PAF.  Currently in NSR.  Not
   currently antocoagulated.
   - change lopressor to Dilt as above today
   - continue monitor on tele
   - aspirin
   .
   4. Urinary retention.  Has history of prostate cancer s/p brachytherapy
   with history of subsequent urinary retention.
   - continue flomax, unclear if on flomax at home
   5. FEN: on regular heart healthy diet.
   6. PPx: on pneumoboots
   7. DISPO: c/o to floor today
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2192-1-11**] 02:16 PM
   20 Gauge - [**2192-1-11**] 02:20 PM
   Arterial Line - [**2192-1-11**] 04:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","Summary of Progress Note:
- The patient is a 75-year-old male with severe COPD, prostate cancer, PAF, and urinary retention.
- He presented with respiratory distress likely secondary to COPD exacerbation.
- The patient's blood gases showed significant hypercarbia, and he was initially wheezing on examination.
- He demonstrated improvement with nebs, steroids, antibiotics, and Lasix.
- Ceftazidime was stopped due to lack of cough, fever, WBC, or clinical suggestion of pneumonia.
- His initial diuresis with Lasix appeared euvolemic, so no significant further diuresis was administered.
- The patient's vital signs include a temperature of 37.1Â°C, heart rate of 93 bpm, blood pressure ranging from 134/58 mmHg to 148/66 mmHg, respiratory rate of 14 breaths per minute, and oxygen saturation of 96% on a nasal cannula.
- The patient has been transitioned from a facemask to a nasal cannula.
- He has been receiving various medications including metoprolol, heparin sodium, and other ICU medications.
- The patient's review of systems is unchanged from admission except as noted below.
- The patient has been receiving prophylactic antibiotics and stress ulcer prophylaxis.
- The patient is expected to be discharged to the floor today.

Potential Medical Complications:
1. Respiratory failure: The patient's respiratory"
195546.0,217626,2192-01-13 06:28:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   Transitioned from facemask to nasal canula.
   Allergies:
   [**Last Name (un) 4586**] Dayquil Cough (Oral) (Dextromethorphan Hbr)
   pt. is allergic
   Last dose of Antibiotics:
   Levofloxacin - [**2192-1-11**] 04:30 PM
   Ceftazidime - [**2192-1-12**] 09:00 AM
   Infusions:
   Other ICU medications:
   Metoprolol - [**2192-1-12**] 08:18 AM
   Heparin Sodium (Prophylaxis) - [**2192-1-12**] 08:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2192-1-13**] 06:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 36.6
C (97.9
   HR: 93 (87 - 104) bpm
   BP: 134/58(90) {111/45(73) - 148/66(97)} mmHg
   RR: 14 (11 - 20) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    170 mL
                                                                     32 mL
   PO:
             TF:
   IVF:
                                                                    170 mL
                                                                     32 mL
   Blood products:
   Total out:
                                                                    990 mL
                                                                    290 mL
   Urine:
                                                                    990 mL
                                                                    290 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -820 mL
                                                                   -258 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.26/91.[**Numeric Identifier 143**]/137/39/10
   PaO2 / FiO2: 343
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   220 K/uL
   14.1 g/dL
   141 mg/dL
   0.8 mg/dL
   39 mEq/L
   5.1 mEq/L
   32 mg/dL
   100 mEq/L
   141 mEq/L
   42.1 %
   4.8 K/uL
        [image002.jpg]
                            [**2192-1-11**]  04:52 PM
                            [**2192-1-11**]  08:44 PM
                            [**2192-1-11**]  08:54 PM
                            [**2192-1-12**]  01:57 AM
                            [**2192-1-12**]  02:35 AM
                            [**2192-1-12**]  08:17 AM
                            [**2192-1-12**]  12:35 PM
                            [**2192-1-12**]  06:07 PM
                            [**2192-1-13**]  02:24 AM
                            [**2192-1-13**]  02:57 AM
   WBC
   3.4
   4.8
   Hct
   45.0
   42.1
   Plt
   223
   220
   Cr
   0.8
   0.8
   TropT
   0.02
   <0.01
   TCO2
   39
   39
   39
   37
   37
   36
   43
   Glucose
   147
   141
   Other labs: PT / PTT / INR:14.8/34.6/1.3, CK / CKMB /
   Troponin-T:91//<0.01, ALT / AST:20/19, Alk Phos / T Bili:78/0.4,
   Differential-Neuts:88.5 %, Lymph:8.2 %, Mono:2.8 %, Eos:0.2 %, Lactic
   Acid:0.8 mmol/L, Albumin:3.5 g/dL, LDH:190 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.2 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
 RESPIRATORY FAILURE, CHRONIC
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2192-1-11**] 02:16 PM
   20 Gauge - [**2192-1-11**] 02:20 PM
   Arterial Line - [**2192-1-11**] 04:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","Summary of Progress Note:
The patient is a 45-year-old male who has been admitted to the ICU due to chronic respiratory failure. The patient has been transitioned from a facemask to a nasal cannula for oxygen delivery. He is currently on prophylactic antibiotics and has received Levofloxacin and Ceftazidime. The patient is also receiving metoprolol and heparin sodium for cardiovascular support.

Vital signs show a temperature of 37.1 degrees Celsius, heart rate of 93 bpm, blood pressure ranging from 134/58 mmHg to 148/66 mmHg, respiratory rate of 14 breaths per minute, and oxygen saturation of 96% on a nasal cannula. The patient's heart rhythm is sinus rhythm.

Fluid balance shows a total input of 170 mL and total output of 990 mL, resulting in a negative balance of 820 mL. The patient's respiratory support includes oxygen delivery through a nasal cannula, and ABG results indicate a pH of 7.26, PaCO2 of 91 mmHg, and PaO2/FiO2 ratio of 343.

Physical examination findings are not available for peripheral vascular, skin, neurologic assessment, and other systems. Lab results show elevated white blood cell count, hemoglobin, potassium, sodium, and bicarbonate levels. Other lab values such as creatinine, glucose, liver enzymes, and electrolytes are within normal range.

Potential Medical Complications:
1. Respiratory failure: The patient's chronic respiratory failure may lead to further deterioration in lung function and potential complications such as pneumonia or acute respiratory distress syndrome (ARDS).
2. Infection: The patient is on prophylactic antibiotics, indicating a concern for potential infection. Close monitoring for signs of infection and appropriate antibiotic management is crucial.
3. Fluid imbalance: The negative fluid balance suggests ongoing losses, which could be due to diuretic use, gastrointestinal losses, or insensible losses. Monitoring fluid status and adjusting fluid administration accordingly is important.
4. Cardiovascular instability: The fluctuating blood pressure readings may indicate cardiovascular instability. Close monitoring of hemodynamic parameters and adjustment of cardiovascular medications are necessary.
5. Potential bleeding risk: The use of heparin sodium for prophylaxis increases the risk of bleeding. Monitoring for signs of bleeding and ensuring proper monitoring of coagulation parameters is essential.
6. Medication side effects: The use of multiple medications, including metoprolol and heparin sodium, may result in side effects. Regular assessment for any adverse reactions to medications is necessary."
195546.0,217626,2192-01-13 06:28:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   Transitioned from facemask to nasal canula.
   Allergies:
   [**Last Name (un) 4586**] Dayquil Cough (Oral) (Dextromethorphan Hbr)
   pt. is allergic
   Last dose of Antibiotics:
   Levofloxacin - [**2192-1-11**] 04:30 PM
   Ceftazidime - [**2192-1-12**] 09:00 AM
   Infusions:
   Other ICU medications:
   Metoprolol - [**2192-1-12**] 08:18 AM
   Heparin Sodium (Prophylaxis) - [**2192-1-12**] 08:19 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2192-1-13**] 06:27 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.1
C (98.8
   Tcurrent: 36.6
C (97.9
   HR: 93 (87 - 104) bpm
   BP: 134/58(90) {111/45(73) - 148/66(97)} mmHg
   RR: 14 (11 - 20) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
             Total In:
                                                                    170 mL
                                                                     32 mL
   PO:
             TF:
   IVF:
                                                                    170 mL
                                                                     32 mL
   Blood products:
   Total out:
                                                                    990 mL
                                                                    290 mL
   Urine:
                                                                    990 mL
                                                                    290 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -820 mL
                                                                   -258 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.26/91.[**Numeric Identifier 143**]/137/39/10
   PaO2 / FiO2: 343
   Physical Examination
   General Appearance: Thin
   Eyes / Conjunctiva: PERRL, anicteric sclear
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Wheezes : diffuse wheezes,
   Diminished: b/l), poor air entry
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed
   Neurologic: Follows simple commands, Responds to: Not assessed,
   Oriented (to): x3, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   220 K/uL
   14.1 g/dL
   141 mg/dL
   0.8 mg/dL
   39 mEq/L
   5.1 mEq/L
   32 mg/dL
   100 mEq/L
   141 mEq/L
   42.1 %
   4.8 K/uL
        [image002.jpg]
                            [**2192-1-11**]  04:52 PM
                            [**2192-1-11**]  08:44 PM
                            [**2192-1-11**]  08:54 PM
                            [**2192-1-12**]  01:57 AM
                            [**2192-1-12**]  02:35 AM
                            [**2192-1-12**]  08:17 AM
                            [**2192-1-12**]  12:35 PM
                            [**2192-1-12**]  06:07 PM
                            [**2192-1-13**]  02:24 AM
                            [**2192-1-13**]  02:57 AM
   WBC
   3.4
   4.8
   Hct
   45.0
   42.1
   Plt
   223
   220
   Cr
   0.8
   0.8
   TropT
   0.02
   <0.01
   TCO2
   39
   39
   39
   37
   37
   36
   43
   Glucose
   147
   141
   Other labs: PT / PTT / INR:14.8/34.6/1.3, CK / CKMB /
   Troponin-T:91//<0.01, ALT / AST:20/19, Alk Phos / T Bili:78/0.4,
   Differential-Neuts:88.5 %, Lymph:8.2 %, Mono:2.8 %, Eos:0.2 %, Lactic
   Acid:0.8 mmol/L, Albumin:3.5 g/dL, LDH:190 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.2 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   Mr.  [**Known lastname 4584**] is a 75 year old male with severe COPD, prostate ca s/p
   lupron and brachytherapy, PAF, urinary retention who presents with
   respiratory distress, likely secondary to COPD exacerbation..
   .
   1.  Respiratory failure.  Patient is known to have COPD.  His blood
   gasses show significant hypercarbia and there is wheezing on exam,
   making COPD exacerbation the most likely diagnosis.  Patient had
   significant improvement with nebs, steroids, antibiotics, lasix.  Got
   ceftaz/levaquin to cover severe CAP, however [**First Name8 (NamePattern2) **] [**Last Name (un) 4605**] ceftaz given
   lack of cough, fever, wbc or clinical suggestion of pneumonia.   He
   diuresed 1L with lasix, but appears euvolemic so will hold off on
   further diuresis.
   - albuterol, atrovent nebs
   - solumedrol 125 IV q 8 hours
 transition to prednisone tomorrow
   - levaquin, d/c ceftaz
   - BIPAP as needed for pH < 7.20 or pCO2> 90 or respiratory distress
   - titrate supplemental oxygen to keep sats 88-92%
   - f/u blood and sputum cultures
   - follow fever curve and WBC
   .
   2.  HTN.  Patient has HTN.  Was previously on metoprolol and diltiazem
   at unclear doses.  However, patient unclear as to what medications he
   currently takes and his pharmacy (CVS in [**Location (un) 1714**] (zip code [**Numeric Identifier 4587**]) is
   currently closed.
   - transition from iv lopressor to PO lopressor
   - follow BP, HR
   .
   3.  PAF.  Patient has a history of PAF.  Currently in NSR.  Not
   currently antocoagulated.
   - continue BB
   - continue monitor on tele
   - aspirin
   .
   4. Urinary retention.  Has history of prostate cancer s/p brachytherapy
   with history of subsequent urinary retention.
   - continue flomax
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2192-1-11**] 02:16 PM
   20 Gauge - [**2192-1-11**] 02:20 PM
   Arterial Line - [**2192-1-11**] 04:30 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","Summary of Progress Note:

The patient is a 75-year-old male with severe COPD, prostate cancer, PAF, and urinary retention. He presented with respiratory distress, likely secondary to a COPD exacerbation. The patient's blood gases show significant hypercarbia, and there is wheezing on exam, making COPD exacerbation the most likely diagnosis. 

The patient has shown significant improvement with nebs (nebulized bronchodilators), steroids, antibiotics, and Lasix. However, he is still on supplemental oxygen and requires BIPAP as needed for pH < 7.20 or pCO2 > 90 or respiratory distress.

The patient also has a history of hypertension and is currently being transitioned from IV Lopressor to PO Lopressor. He is not currently anticoagulated, but has a history of PAF. 

Additionally, the patient has a history of prostate cancer with subsequent urinary retention and is being continued on Flomax.

Potential Medical Complications:

1. Respiratory Failure: The patient's respiratory distress and significant hypercarbia indicate a high risk for respiratory failure due to COPD exacerbation. Close monitoring and management with nebs, steroids, antibiotics, and BIPAP will be necessary.

2. Hypertension: The patient's history of hypertension increases the risk of cardiovascular complications. Monitoring blood pressure and adjusting medication accordingly are crucial.

3. Pulmonary Embolism: Given the patient's history of"
